Table of Content

1 Endometriosis Market Overview
1.1 Product Overview and Scope of Endometriosis
1.2 Endometriosis Segment by Type
1.2.1 Global Endometriosis Market Value Comparison by Type (2024-2034)
1.2.2 Gonadotropins Releasing Hormone Agonists
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Progestin
1.2.5 Oral Contraceptive Pills
1.3 Endometriosis Segment by Application
1.3.1 Global Endometriosis Market Value by Application: (2024-2034)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Other
1.4 Global Endometriosis Market Size Estimates and Forecasts
1.4.1 Global Endometriosis Revenue 2018-2034
1.4.2 Global Endometriosis Sales 2018-2034
1.4.3 Global Endometriosis Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Endometriosis Market Competition by Manufacturers
2.1 Global Endometriosis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Endometriosis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Endometriosis Average Price by Manufacturers (2018-2023)
2.4 Global Endometriosis Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Endometriosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endometriosis, Product Type & Application
2.7 Endometriosis Market Competitive Situation and Trends
2.7.1 Endometriosis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endometriosis Players Market Share by Revenue
2.7.3 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endometriosis Retrospective Market Scenario by Region
3.1 Global Endometriosis Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Endometriosis Global Endometriosis Sales by Region: 2018-2034
3.2.1 Global Endometriosis Sales by Region: 2018-2023
3.2.2 Global Endometriosis Sales by Region: 2024-2034
3.3 Global Endometriosis Global Endometriosis Revenue by Region: 2018-2034
3.3.1 Global Endometriosis Revenue by Region: 2018-2023
3.3.2 Global Endometriosis Revenue by Region: 2024-2034
3.4 North America Endometriosis Market Facts & Figures by Country
3.4.1 North America Endometriosis Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Endometriosis Sales by Country (2018-2034)
3.4.3 North America Endometriosis Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endometriosis Market Facts & Figures by Country
3.5.1 Europe Endometriosis Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Endometriosis Sales by Country (2018-2034)
3.5.3 Europe Endometriosis Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endometriosis Market Facts & Figures by Country
3.6.1 Asia Pacific Endometriosis Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Endometriosis Sales by Country (2018-2034)
3.6.3 Asia Pacific Endometriosis Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endometriosis Market Facts & Figures by Country
3.7.1 Latin America Endometriosis Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Endometriosis Sales by Country (2018-2034)
3.7.3 Latin America Endometriosis Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endometriosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Endometriosis Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Endometriosis Sales by Country (2018-2034)
3.8.3 Middle East and Africa Endometriosis Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endometriosis Sales by Type (2018-2034)
4.1.1 Global Endometriosis Sales by Type (2018-2023)
4.1.2 Global Endometriosis Sales by Type (2024-2034)
4.1.3 Global Endometriosis Sales Market Share by Type (2018-2034)
4.2 Global Endometriosis Revenue by Type (2018-2034)
4.2.1 Global Endometriosis Revenue by Type (2018-2023)
4.2.2 Global Endometriosis Revenue by Type (2024-2034)
4.2.3 Global Endometriosis Revenue Market Share by Type (2018-2034)
4.3 Global Endometriosis Price by Type (2018-2034)
5 Segment by Application
5.1 Global Endometriosis Sales by Application (2018-2034)
5.1.1 Global Endometriosis Sales by Application (2018-2023)
5.1.2 Global Endometriosis Sales by Application (2024-2034)
5.1.3 Global Endometriosis Sales Market Share by Application (2018-2034)
5.2 Global Endometriosis Revenue by Application (2018-2034)
5.2.1 Global Endometriosis Revenue by Application (2018-2023)
5.2.2 Global Endometriosis Revenue by Application (2024-2034)
5.2.3 Global Endometriosis Revenue Market Share by Application (2018-2034)
5.3 Global Endometriosis Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Endometriosis Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Endometriosis Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Bayer HealthCare
6.3.1 Bayer HealthCare Corporation Information
6.3.2 Bayer HealthCare Description and Business Overview
6.3.3 Bayer HealthCare Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer HealthCare Endometriosis Product Portfolio
6.3.5 Bayer HealthCare Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Endometriosis Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Addex Therapeutics
6.5.1 Addex Therapeutics Corporation Information
6.5.2 Addex Therapeutics Description and Business Overview
6.5.3 Addex Therapeutics Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Addex Therapeutics Endometriosis Product Portfolio
6.5.5 Addex Therapeutics Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Astellas Pharma Endometriosis Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Debiopharm
6.6.1 Debiopharm Corporation Information
6.6.2 Debiopharm Description and Business Overview
6.6.3 Debiopharm Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Debiopharm Endometriosis Product Portfolio
6.7.5 Debiopharm Recent Developments/Updates
6.8 ElexoPharm
6.8.1 ElexoPharm Corporation Information
6.8.2 ElexoPharm Description and Business Overview
6.8.3 ElexoPharm Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ElexoPharm Endometriosis Product Portfolio
6.8.5 ElexoPharm Recent Developments/Updates
6.9 EndoCeutics
6.9.1 EndoCeutics Corporation Information
6.9.2 EndoCeutics Description and Business Overview
6.9.3 EndoCeutics Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.9.4 EndoCeutics Endometriosis Product Portfolio
6.9.5 EndoCeutics Recent Developments/Updates
6.10 Euroscreen
6.10.1 Euroscreen Corporation Information
6.10.2 Euroscreen Description and Business Overview
6.10.3 Euroscreen Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Euroscreen Endometriosis Product Portfolio
6.10.5 Euroscreen Recent Developments/Updates
6.11 Forendo Pharma
6.11.1 Forendo Pharma Corporation Information
6.11.2 Forendo Pharma Endometriosis Description and Business Overview
6.11.3 Forendo Pharma Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Forendo Pharma Endometriosis Product Portfolio
6.11.5 Forendo Pharma Recent Developments/Updates
6.12 Kissei Pharmaceutical
6.12.1 Kissei Pharmaceutical Corporation Information
6.12.2 Kissei Pharmaceutical Endometriosis Description and Business Overview
6.12.3 Kissei Pharmaceutical Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kissei Pharmaceutical Endometriosis Product Portfolio
6.12.5 Kissei Pharmaceutical Recent Developments/Updates
6.13 Neurocrine Biosciences
6.13.1 Neurocrine Biosciences Corporation Information
6.13.2 Neurocrine Biosciences Endometriosis Description and Business Overview
6.13.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Neurocrine Biosciences Endometriosis Product Portfolio
6.13.5 Neurocrine Biosciences Recent Developments/Updates
6.14 Nippon Shinyaku
6.14.1 Nippon Shinyaku Corporation Information
6.14.2 Nippon Shinyaku Endometriosis Description and Business Overview
6.14.3 Nippon Shinyaku Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nippon Shinyaku Endometriosis Product Portfolio
6.14.5 Nippon Shinyaku Recent Developments/Updates
6.15 Takeda
6.15.1 Takeda Corporation Information
6.15.2 Takeda Endometriosis Description and Business Overview
6.15.3 Takeda Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Takeda Endometriosis Product Portfolio
6.15.5 Takeda Recent Developments/Updates
6.16 Bayer AG
6.16.1 Bayer AG Corporation Information
6.16.2 Bayer AG Endometriosis Description and Business Overview
6.16.3 Bayer AG Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Bayer AG Endometriosis Product Portfolio
6.16.5 Bayer AG Recent Developments/Updates
6.17 Neurocrine Biosciences
6.17.1 Neurocrine Biosciences Corporation Information
6.17.2 Neurocrine Biosciences Endometriosis Description and Business Overview
6.17.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Neurocrine Biosciences Endometriosis Product Portfolio
6.17.5 Neurocrine Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endometriosis Industry Chain Analysis
7.2 Endometriosis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endometriosis Production Mode & Process
7.4 Endometriosis Sales and Marketing
7.4.1 Endometriosis Sales Channels
7.4.2 Endometriosis Distributors
7.5 Endometriosis Customers
8 Endometriosis Market Dynamics
8.1 Endometriosis Industry Trends
8.2 Endometriosis Market Drivers
8.3 Endometriosis Market Challenges
8.4 Endometriosis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Endometriosis Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Endometriosis Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Endometriosis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Endometriosis Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Endometriosis Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Endometriosis Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Endometriosis Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Endometriosis Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Endometriosis, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Endometriosis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Endometriosis, Product Type & Application
Table 12. Global Key Manufacturers of Endometriosis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endometriosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Endometriosis Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Endometriosis Sales by Region (2018-2023) & (K Units)
Table 18. Global Endometriosis Sales Market Share by Region (2018-2023)
Table 19. Global Endometriosis Sales by Region (2024-2034) & (K Units)
Table 20. Global Endometriosis Sales Market Share by Region (2024-2034)
Table 21. Global Endometriosis Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Endometriosis Revenue Market Share by Region (2018-2023)
Table 23. Global Endometriosis Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Endometriosis Revenue Market Share by Region (2024-2034)
Table 25. North America Endometriosis Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Endometriosis Sales by Country (2018-2023) & (K Units)
Table 27. North America Endometriosis Sales by Country (2024-2034) & (K Units)
Table 28. North America Endometriosis Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Endometriosis Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Endometriosis Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Endometriosis Sales by Country (2018-2023) & (K Units)
Table 32. Europe Endometriosis Sales by Country (2024-2034) & (K Units)
Table 33. Europe Endometriosis Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Endometriosis Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Endometriosis Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Endometriosis Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Endometriosis Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Endometriosis Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Endometriosis Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Endometriosis Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Endometriosis Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Endometriosis Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Endometriosis Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Endometriosis Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Endometriosis Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Endometriosis Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Endometriosis Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Endometriosis Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Endometriosis Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Endometriosis Sales (K Units) by Type (2018-2023)
Table 51. Global Endometriosis Sales (K Units) by Type (2024-2034)
Table 52. Global Endometriosis Sales Market Share by Type (2018-2023)
Table 53. Global Endometriosis Sales Market Share by Type (2024-2034)
Table 54. Global Endometriosis Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Endometriosis Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Endometriosis Revenue Market Share by Type (2018-2023)
Table 57. Global Endometriosis Revenue Market Share by Type (2024-2034)
Table 58. Global Endometriosis Price (USD/Unit) by Type (2018-2023)
Table 59. Global Endometriosis Price (USD/Unit) by Type (2024-2034)
Table 60. Global Endometriosis Sales (K Units) by Application (2018-2023)
Table 61. Global Endometriosis Sales (K Units) by Application (2024-2034)
Table 62. Global Endometriosis Sales Market Share by Application (2018-2023)
Table 63. Global Endometriosis Sales Market Share by Application (2024-2034)
Table 64. Global Endometriosis Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Endometriosis Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Endometriosis Revenue Market Share by Application (2018-2023)
Table 67. Global Endometriosis Revenue Market Share by Application (2024-2034)
Table 68. Global Endometriosis Price (USD/Unit) by Application (2018-2023)
Table 69. Global Endometriosis Price (USD/Unit) by Application (2024-2034)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Endometriosis Product
Table 74. AbbVie Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Endometriosis Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Bayer HealthCare Corporation Information
Table 81. Bayer HealthCare Description and Business Overview
Table 82. Bayer HealthCare Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Bayer HealthCare Endometriosis Product
Table 84. Bayer HealthCare Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Endometriosis Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Addex Therapeutics Corporation Information
Table 91. Addex Therapeutics Description and Business Overview
Table 92. Addex Therapeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Addex Therapeutics Endometriosis Product
Table 94. Addex Therapeutics Recent Developments/Updates
Table 95. Astellas Pharma Corporation Information
Table 96. Astellas Pharma Description and Business Overview
Table 97. Astellas Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Astellas Pharma Endometriosis Product
Table 99. Astellas Pharma Recent Developments/Updates
Table 100. Debiopharm Corporation Information
Table 101. Debiopharm Description and Business Overview
Table 102. Debiopharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Debiopharm Endometriosis Product
Table 104. Debiopharm Recent Developments/Updates
Table 105. ElexoPharm Corporation Information
Table 106. ElexoPharm Description and Business Overview
Table 107. ElexoPharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. ElexoPharm Endometriosis Product
Table 109. ElexoPharm Recent Developments/Updates
Table 110. EndoCeutics Corporation Information
Table 111. EndoCeutics Description and Business Overview
Table 112. EndoCeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. EndoCeutics Endometriosis Product
Table 114. EndoCeutics Recent Developments/Updates
Table 115. Euroscreen Corporation Information
Table 116. Euroscreen Description and Business Overview
Table 117. Euroscreen Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Euroscreen Endometriosis Product
Table 119. Euroscreen Recent Developments/Updates
Table 120. Forendo Pharma Corporation Information
Table 121. Forendo Pharma Description and Business Overview
Table 122. Forendo Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Forendo Pharma Endometriosis Product
Table 124. Forendo Pharma Recent Developments/Updates
Table 125. Kissei Pharmaceutical Corporation Information
Table 126. Kissei Pharmaceutical Description and Business Overview
Table 127. Kissei Pharmaceutical Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Kissei Pharmaceutical Endometriosis Product
Table 129. Kissei Pharmaceutical Recent Developments/Updates
Table 130. Neurocrine Biosciences Corporation Information
Table 131. Neurocrine Biosciences Description and Business Overview
Table 132. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Neurocrine Biosciences Endometriosis Product
Table 134. Neurocrine Biosciences Recent Developments/Updates
Table 135. Nippon Shinyaku Corporation Information
Table 136. Nippon Shinyaku Description and Business Overview
Table 137. Nippon Shinyaku Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Nippon Shinyaku Endometriosis Product
Table 139. Nippon Shinyaku Recent Developments/Updates
Table 140. Takeda Corporation Information
Table 141. Takeda Description and Business Overview
Table 142. Takeda Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Takeda Endometriosis Product
Table 144. Takeda Recent Developments/Updates
Table 145. Bayer AG Corporation Information
Table 146. Bayer AG Description and Business Overview
Table 147. Bayer AG Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Bayer AG Endometriosis Product
Table 149. Bayer AG Recent Developments/Updates
Table 150. Neurocrine Biosciences Corporation Information
Table 151. Neurocrine Biosciences Description and Business Overview
Table 152. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Neurocrine Biosciences Endometriosis Product
Table 154. Neurocrine Biosciences Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Endometriosis Distributors List
Table 158. Endometriosis Customers List
Table 159. Endometriosis Market Trends
Table 160. Endometriosis Market Drivers
Table 161. Endometriosis Market Challenges
Table 162. Endometriosis Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endometriosis
Figure 2. Global Endometriosis Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Endometriosis Market Share by Type in 2024 & 2034
Figure 4. Gonadotropins Releasing Hormone Agonists Product Picture
Figure 5. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 6. Progestin Product Picture
Figure 7. Oral Contraceptive Pills Product Picture
Figure 8. Global Endometriosis Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Endometriosis Market Share by Application in 2024 & 2034
Figure 10. Hospital Use
Figure 11. Clinic Use
Figure 12. Other
Figure 13. Global Endometriosis Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Endometriosis Market Size (2018-2034) & (US$ Million)
Figure 15. Global Endometriosis Sales (2018-2034) & (K Units)
Figure 16. Global Endometriosis Average Price (USD/Unit) & (2018-2034)
Figure 17. Endometriosis Report Years Considered
Figure 18. Endometriosis Sales Share by Manufacturers in 2024
Figure 19. Global Endometriosis Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Endometriosis Players: Market Share by Revenue in 2024
Figure 21. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Endometriosis Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Endometriosis Sales Market Share by Country (2018-2034)
Figure 24. North America Endometriosis Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Endometriosis Sales Market Share by Country (2018-2034)
Figure 28. Europe Endometriosis Revenue Market Share by Country (2018-2034)
Figure 29. Germany Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Endometriosis Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Endometriosis Revenue Market Share by Region (2018-2034)
Figure 36. China Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Endometriosis Sales Market Share by Country (2018-2034)
Figure 47. Latin America Endometriosis Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Endometriosis Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Endometriosis Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Endometriosis Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Endometriosis by Type (2018-2034)
Figure 57. Global Revenue Market Share of Endometriosis by Type (2018-2034)
Figure 58. Global Endometriosis Price (USD/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Endometriosis by Application (2018-2034)
Figure 60. Global Revenue Market Share of Endometriosis by Application (2018-2034)
Figure 61. Global Endometriosis Price (USD/Unit) by Application (2018-2034)
Figure 62. Endometriosis Value Chain
Figure 63. Endometriosis Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed